Accelrys is very pleased to announce the release of the latest version of Discovery Studio 3.5 – our most complete and integrated solution for both small molecule and biotherapeutics-based research. Version 3.5 includes many new features and enhancements including:
- New Small Molecules Science
- New ligand profiling database for drug repurposing or to study side effects
- New in-situ FBDD lead optimization tools
- New in-situ FBDD core-hopping tools
- New Matched Molecular Pairs-based Activity Cliffs analysis
- New ligand profiling database for drug repurposing or to study side effects
- New and Updated Biotherapeutics Science
- New Developability Index calculations to rank protein-protein aggregation
- New capability to perform pH-dependent mutation energy calculations
- Antibody loop modelling enhancements including canonical structure type filtering and updated antibody structure databases
- Integration with standard biologics naming schemes: IMGT, Chotia, Honegger, Kabat
- New Developability Index calculations to rank protein-protein aggregation
- Partner Science
- CHARMm upgraded to version c36b2
- MODELER upgraded to version 9v10
- CHARMm upgraded to version c36b2
- Visualization and Performance
- Improved toolkit for creating and visualizing receptor-ligand surfaces
- Improved support for low specification graphics cards
- Updated free DS Visualizer to v3.5
- Updated free 3D plug-in DS ActiveX Control to v3.5
- Improved toolkit for creating and visualizing receptor-ligand surfaces
Learn how to accelerate molecular simulations for your drug discovery research, with Discovery Studio ® 3.5! Register now for our live webinar series
